Generic Drug Analysis & Statistics, January 2013 (p20)

Talk to Amrita

+1 718 303 2019

All regions

571-610 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets

Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets

  • $ 3 500
  • Industry report
  • December 2010
  • by GBI Research

Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets Summary GBI Research's new report, ?Patent Strategies - Effective Strategies for Extension ...

  • Industries : Generic Drug
  • Countries : World
Biosimilars Business Review

Biosimilars Business Review

  • $ 701
  • Industry report
  • November 2010
  • by Espicom Business Intelligence

A business review of, and commentary on, the developments that are shaping this rapidly evolving and often contentious sector of the generic drug industry. Few areas of the generics market are proving ...

  • Industries : Generic Drug, Biotechnology
  • Countries : United States
Partnering in the Global Generics Industry 2010: A guide to companies

Partnering in the Global Generics Industry 2010: A guide to companies

  • $ 1 004
  • Industry report
  • October 2010
  • by Espicom Business Intelligence

Facts, statistics and insights on 168 medium-sized generic manufacturers from 40 countries The operating environment for generics companies is changing rapidly as the industry matures and growth focuses ...

  • Industries : Generic Drug
The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses

The 2011 Leading Pharmaceutical Companies Product Portfolio Analyses

  • $ 1 850
  • Industry report
  • October 2010
  • by Venture Planning Group

For each company, the analyses present:Extensive review of major ethical, OTC, and generic drugs.Most recent new drug introductions and indications.The companies analyzed in the report:        -   ...

  • Industries : Generic Drug
Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth

Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth

  • $ 3 500
  • Industry report
  • October 2010
  • by GBI Research

Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth Summary GBI Research has released its Chemical research, ?Active Pharmaceutical Ingredients ...

  • Industries : It Hosting, Biotechnology, Generic Drug
World Generic Drug Market Outlook 2010-2025

World Generic Drug Market Outlook 2010-2025

  • $ 2 330
  • Industry report
  • September 2010
  • by Visiongain

Report Details - where will the greatest opportunities for generic drug sales occur? Our new report will show you revenue prospects for the generic drug market from 2010 onwards. Where will the best growth ...

  • Industries : Generic Drug
  • Countries : World
Southeast Asian Pharmaceuticals Industry: Generic Drug Market

Southeast Asian Pharmaceuticals Industry: Generic Drug Market

  • $ 10 000
  • Industry report
  • September 2010
  • by Frost & Sullivan

This Market Engineering research service has been developed to address the generics drug market in Southeast Asia that includes Malaysia, Philippines, Singapore and Thailand. This research service presents ...

  • Industries : Generic Drug
  • Countries : Philippines, Singapore, Asia, Thailand, Malaysia
Healthcare Industry Overview in Ethiopia

Healthcare Industry Overview in Ethiopia

  • $ 7 500
  • Industry report
  • July 2010
  • by Frost & Sullivan

Healthcare Industry Overview in Ethiopia provides an overview of the healthcare system in Ethiopia as well as a brief overview of the pharmaceutical industry. In terms of the healthcare environment, the ...

  • Industries : Generic Drug, Healthcare
  • Countries : Ethiopia
  Fipronil Survey  in China

Fipronil Survey in China

  • $ 11 917
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Export Analysis of Fipronil in China

Export Analysis of Fipronil in China

  • $ 1 609
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Fipronil Technology in China

Fipronil Technology in China

  • $ 804
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Forecast of Fipronil in China

Forecast of Fipronil in China

  • $ 804
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Influential factors of Fipronil industry in China

Influential factors of Fipronil industry in China

  • $ 1 287
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
Production and Consumption of Fipronil in China

Production and Consumption of Fipronil in China

  • $ 1 287
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
  Fipronil Survey  in China

Fipronil Survey in China

  • $ 11 917
  • Industry report
  • June 2010
  • by CCM International Limited

Fipronil is an outstanding insecticide and has played an important role in pest control in China. However, owing to the harmful effect of fipronil on shellfishes and bees, Chinese government has restricted ...

  • Industries : Generic Drug
  • Countries : China
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets

The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets

  • $ 3 500
  • Industry report
  • May 2010
  • by GBI Research

The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets Summary GBI Research's report, ?The Future of Ophthalmology Therapeutics, ...

  • Industries : Therapy, Generic Drug, Drug Discovery and Development
  • Countries : World
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry

Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry

  • $ 300
  • Industry report
  • May 2010
  • by Aruvian's R'search

A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use. Generic drugs are less expensive because generic manufacturers ...

  • Industries : Generic Drug
  • Countries : United States
German Pharma Sector Analysis

German Pharma Sector Analysis

  • $ 600
  • Industry report
  • April 2010
  • by RNCOS

Germany is one of the largest pharmaceutical markets in the world. Most of the pharma companies in Germany are focused on research, which has led the country to become one of the most advanced pharma markets ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : Germany
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010

Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010

  • $ 1 681
  • Industry report
  • March 2010
  • by Espicom Business Intelligence

With high-profile inhalable drugs coming off patent, the prospects for the generic sector should be good - but only if companies can overcome production, regulatory and litigation hurdles. The inhalation ...

  • Industries : Drug and Medication, Generic Drug
  • Countries : United States
Strategic Alliances: Synergistic Path To Value Creation

Strategic Alliances: Synergistic Path To Value Creation

  • $ 2 995
  • Industry report
  • January 2010
  • by CHI Insight Pharma Reports

As the first decade of the 21st century comes to an end, the pharmaceutical industry is facing a major revenue downturn. The contributing factors are the expiration of patents on a number of blockbuste ...

  • Industries : Generic Drug, Pharmaceutical
The Future of  Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

The Future of  Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

  • $ 3 500
  • Industry report
  • December 2009
  • by GBI Research

Summary The author has released its latest research ?The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways?. The report provides insights on the biosimilars ...

  • Industries : Generic Drug
  • Countries : World, Europe, United States, Japan
Barr Pharmaceuticals Generics Company Intelligence Report

Barr Pharmaceuticals Generics Company Intelligence Report

  • $ 331
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Barr Pharmaceuticals is one of the USA's leading generic manufacturers. The company has a policy of early market entry for generics, and as such is generally involved in a large amount of litigation. ...

  • Industries : General Medicine and Specialty Medicine, Generic Drug
Pliva Generics Company Intelligence Report

Pliva Generics Company Intelligence Report

  • $ 331
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Pliva is based in Croatia, and is one of that country's leading manufacturing companies. It is also one of the largest pharmaceutical manufacturers in central Europe. It was privatised in the mid 1990s. ...

  • Industries : Generic Drug
  • Countries : United States
Zentiva Generics Company Intelligence Report

Zentiva Generics Company Intelligence Report

  • $ 331
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Zentiva was created through the merger of the Czech company, Léciva, and the Slovak firm Slovakofarma, which was completed in August 2003. The two former companies began selling products under the Zentiva ...

  • Industries : Generic Drug
  • Countries : Turkey, Slovakia (slovak Republic), Czech Republic, Europe, Lithuania, Ukraine, Russian Federation, Romania, Poland, Latvia, Bulgaria, World
Japanese Pharmaceutical Market, 2009-2024

Japanese Pharmaceutical Market, 2009-2024

  • $ 2 330
  • Industry report
  • October 2009
  • by Visiongain

Report Details How will the world's second-largest pharma market shape up in the future? What effects will policy shifts and an increasing move to generics have? Our new report explains. Japan is the second-largest ...

  • Industries : Generic Drug
  • Countries : Japan
The Pharmaceutical Industry in Botswana

The Pharmaceutical Industry in Botswana

  • $ 7 500
  • Industry report
  • September 2009
  • by Frost & Sullivan

This research service presents an in-depth analysis of the Botswana pharmaceutical industry. It provides a general insight into processes of regulations, medical insurance, healthcare procurement and financing. ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : Botswana
World Generics Market 2009-2024

World Generics Market 2009-2024

  • $ 2 330
  • Industry report
  • August 2009
  • by Visiongain

Impending patent expiries, increasing competition and changes in legislation: where will generics go from 2009 onwards? Our new report - World Generics Market 2009-2024 - explains the opportunities and ...

  • Industries : Generic Drug, Pharmaceutical
  • Countries : World
Emerging Opportunities in Controlled-Release Generic Drugs

Emerging Opportunities in Controlled-Release Generic Drugs

  • $ 1 681
  • Industry report
  • August 2009
  • by Espicom Business Intelligence

From emerging specialist companies to established generic producers, alternative drug delivery technologies are increasingly being seen as a route to a competitive edge in the generics industry. While ...

  • Industries : Generic Drug, Drug Delivery Technology
  • Countries : United States
North America Active Pharmaceutical Ingredients Industry, Market Overview and Outlook to 2020

North America Active Pharmaceutical Ingredients Industry, Market Overview and Outlook to 2020

  • $ 1 500
  • Industry report
  • August 2009
  • by Global Markets Direct

The report will provide in-depth analysis of volume and revenue of the Active Pharmaceutical Ingredients industry in North America. The pricing trend of the industry will also be analyzed in the report. ...

  • Industries : Generic Drug, Chemical
  • Countries : North America
Europe Active Pharmaceutical Ingredients Industry, Market Overview and Outlook to 2020

Europe Active Pharmaceutical Ingredients Industry, Market Overview and Outlook to 2020

  • $ 1 500
  • Industry report
  • July 2009
  • by Global Markets Direct

The report will provide in-depth analysis of volume and revenue of the Active Pharmaceutical Ingredients industry in Europe. The pricing trend of the industry will also be analyzed in the report. This ...

  • Industries : Generic Drug, Chemical
  • Countries : Europe
About 400 reports

Download Unlimited Documents from Trusted Public Sources

Biosimilars Market Forecast in Europe

  • After Generics It's the Turn of Biosimilars, a Budding Market
  • September 2014
    2 pages
  • Biosimilars  

    Drug  

  • Europe  

    Spain  

    World  

View report >

8 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Mylan Inc.

United States

Teva Pharmaceuticals

United States

Bayer AG

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.